PCAC

The Pharmacy Compounding Advisory Committee, a standing FDA advisory committee of outside experts who review nominated bulk drug substances — including research peptides — and give the agency nonbinding recommendations on compounding eligibility. PCAC does not vote on drug approval and has no independent authority to add a substance to FDA's 503A Bulks List.